|
INTERVIEW:
Tom Blackett, Deputy Chairman, Interbrand Group
"Now Is The Time For Brands In India"
An Indophile, he claims to have probably
been conceived in India (well, actually he means it!). An avid rugby and
cricket fan, the 54-year-old Deputy Chairman of the world's biggest brand
consultancy, Interbrand Group, Tom Blackett's one burning
ambition has been to watch a test match at Kolkata's Eden Gardens. He may
get lucky very soon. The cricket season is just about beginning in the
sub-continent. More importantly, Interbrand has just struck a strategic
tie-up with the Bangalore-based Equitor Consulting, and Blackett hasn't
been to India since. In an exclusive, free-wheeling telephonic interview
from his London headquarters, Blackett spoke to BT's Shailesh
Dobhal on a host of issues surrounding Interbrand's
gospel on brands and brand valuation. Excerpts:
Q. How do you view Interbrand's business
potential in India?
A. We're very excited about the Indian
market. We have been watching the Indian economy open and get stronger.
Now is the time for brands in India. And what gives Interbrand, with its
brand valuation expertise, a leg-up is how Indian businessmen behave: they
are very hard-nosed and are skeptical of branding and marketing spends.
But the moment you start speaking about actually putting a tangible value
to brands, that moves them... they understand figures. And we can
demonstrate to them, empirically, how to measure investments in brands and
its concomitant value to business. Big consumer product companies and
emerging industries like telecommunications and pharmaceuticals could be
our first clients here. Why, we are here to make just about any industry
help think in a different way, the Interbrand's way of brands being
central to any business.
Has brand valuation moved out of its image
of merely being an ''exercise in shareholder communication''?
THE
LIFE OF A BRAND |
Interbrand
began life in 1974 in london as a specialist in the area of brand
and corporate name development. Later, it added design capabilities
and a legal practice (in the area of international trade marks) to
become one of the first multi-disciplinary branding consultancies.
It was providence that offered
Interbrand its forte of brand valuation. In 1994, Interbrand was
asked by a UK-based food company, Ranks Hovis MacDougall (RHM) to
help fend off a hostile takeover bid by Goodman Fielder Wactie (GFW),
an Australian foods group. Interbrand's brand valuation exercise for
RHM, and the resultant increase in RHM's business value, helped
repel the GFW bid.
In the course of its close
relationship with RHM, Interbrand developed-in collaboration with
the London Business School-its proprietary brand valuation
methodology through cash-flow analysis, brand strength scoring, and
discounted cash-flow valuation. The UK Accounting Standards Board
went on to accept Interbrand's methodology as the basis for balance
sheet valuations of brands.
So far, Interbrand has valued
more than 1,200 of the world's leading brands, including Ford,
Nestlé, Danone, Nabisco, Grand Metropolitan, IBM, Gucci, Chanel,
BP, British Airways, and MCI, with an aggregate value in excess of
$50 billion.
Interbrand's strategic tie-up
with the Bangalore-based Equitor Consulting will give the UK major a
foothold in India. Equitor, on the other hand, will have complete
access to Interbrand's global resources and expertise. The two
companies will explore the possibility of a joint venture at the end
of a year. |
Well, even if most companies just did that,
we would have enlightened business communities! I'll welcome it if more
CEOs, internationally, treat their brands as assets, and at least mention
their value on annual reports if not put it on the balance sheet. It is
only then that the participants of any business will understand how brand
valuation actually helps and impacts in investment allocation, brand
performance, inputs to balanced scorecard, and mergers and acquisition
negotiations.
Do you see CEOs taking active interest in
and spending time on nurturing brands?
Yes. I was at a seminar sometime ago, where
the British Petroleum (BP) Chairman, Lord John Brown, was speaking. And he
spoke of nothing but how the BP brand is central to all its businesses,
and how the brand is the public expression of the organisation, dictating
the organisation's actions, investments, even technologies. For BP is no
longer about plundering the earth for petroleum, but partnering, fairness
and environment. Recently, Dominic Cadbury, Chairman of Cadbury, which
puts the value of Cadbury's brands in its annual report, told me how most
of his time is spent in explaining to shareholders his company's biggest
expenditure head, marketing, and its impact on Cadbury's brand value.
Samsung's Vice President (Global Marketing), San Jin Park, is another
person I know who is passionate about the Samsung brand. Deepak Chopra is
another person who looks into the future of his eponymous brand. But very
often, very many CEOs pay just lip-service to brand building.
Have brand owners started seeing brands as
principal contributors to economic value added (EVA)?
Well, from the brand marketers' point of
view, it is more true in case of fast moving consumer goods (FMCGs), where
anyway there is little value added in terms of anything else but brands.
But it is changing even in industries such as telecommunications, where
traditionally brand EVA was very low. With mobile telephony, where
consumer choice becomes critical for business success, companies have
changed over and realised that investing in brands was adding more EVA to
the business than previously thought.
What implication does waiving of patents
(in case of drugs for public health emergency) have on brands and the
brand valuation process?
In that case brands become all the more
important. Look at the way the pharmaceutical industry has operated:
industry mentality is to invest heavily in research and development and
then push for product monopoly through patents. Milk the patent and then
move on to newer products. They do not have a long-term brand building
perspective the way FMCG companies have. But what happens in a case such
as Bayer almost losing its Cipro patent in USA on account of the anthrax
scare? The brand then becomes a psychological monopoly, and pharma
companies are realising this as more and more consumers are becoming part
of the healthcare dialogue and ethicals moving to over-the-counter.
This may sound a trifle basic, but how
would you define a brand?
Some people may say that it is a name. To me,
it is a set of impressions that sit on the consumers' mind and is the
basis of a relationship. And those impressions decide what kind of
relationship the consumer will have with the brand and where.
So is Pepsi, according to you, only an
aerated beverages brand? Or Coke, for that matter? Do you see that as a
strength or a weakness?
I am a firm believer in a company sticking to
its knitting. To me brand Coke is a brown, sweet stuff that pours out from
a red can. Blue can in case of Pepsi. You can give me de-caffeinated, diet
et al., but I will still expect brown sweet stuff to pour out of the can.
That's the point: you have to respect the consumer's intelligence and not
complicate things.
|